BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao X, Huang M, Liu L, He Y, Yu Q, Zhao H, Zhou C, Zhang J, Zhu Z, Wan J, Jiang X, Gao Y. Insertion/deletion polymorphisms in the promoter region of BRM contribute to risk of hepatocellular carcinoma in Chinese populations. PLoS One 2013;8:e55169. [PMID: 23359823 DOI: 10.1371/journal.pone.0055169] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Wu S, Zhou X, Huang F, Chen R, Wang Y, Wu J. Association between nucleotide excision repair gene polymorphism and colorectal cancer risk. J Clin Lab Anal 2019;33:e22956. [PMID: 31568607 DOI: 10.1002/jcla.22956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cheng Z, Guo Y, Ming L. Functional Foxp3 polymorphisms and the susceptibility to cancer: An update meta-analysis. Medicine (Baltimore) 2018;97:e11927. [PMID: 30142808 DOI: 10.1097/MD.0000000000011927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yu Y, Cheng D, Parfrey P, Liu G, Savas S. Two functional indel polymorphisms in the promoter region of the Brahma gene (BRM) and disease risk and progression-free survival in colorectal cancer. PLoS One 2018;13:e0198873. [PMID: 29894502 DOI: 10.1371/journal.pone.0198873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Korpanty GJ, Eng L, Qiu X, Faluyi OO, Renouf DJ, Cheng D, Patel D, Chen Z, Tse BC, Knox JJ, Dodbiba L, Teichman J, Azad AK, Wong R, Darling G, Reisman D, Cuffe S, Liu G, Xu W. Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcome. Oncotarget 2017;8:28093-100. [PMID: 28427211 DOI: 10.18632/oncotarget.15890] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Savas S, Skardasi G. The SWI/SNF complex subunit genes: Their functions, variations, and links to risk and survival outcomes in human cancers. Crit Rev Oncol Hematol 2018;123:114-31. [PMID: 29482773 DOI: 10.1016/j.critrevonc.2018.01.009] [Cited by in Crossref: 38] [Cited by in F6Publishing: 48] [Article Influence: 9.5] [Reference Citation Analysis]
6 Pasic I, Wong KM, Lee JJ, Espin-Garcia O, Brhane Y, Cheng D, Chen Z, Patel D, Brown C, Bucur R, Reisman D, Knox JJ, Xu W, Hung RJ, Liu G, Cleary SP. Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma. Mol Carcinog 2018;57:106-13. [PMID: 28892201 DOI: 10.1002/mc.22736] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
7 Li XY, Zhang C, Zhang QL, Zhu JL, Liu Q, Chen MW, Yang XM, Hui WL, Cui YL. Sensitive genotyping of mutations in the EGFR gene from NSCLC patients using PCR-GoldMag lateral flow device. Sci Rep 2017;7:8346. [PMID: 28827701 DOI: 10.1038/s41598-017-08210-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Liu G, Cuffe S, Liang S, Azad AK, Cheng L, Brhane Y, Qiu X, Cescon DW, Bruce J, Chen Z, Cheng D, Patel D, Tse BC, Laurie SA, Goss G, Leighl NB, Hung R, Bradbury PA, Seymour L, Shepherd FA, Tsao MS, Chen BE, Xu W, Reisman DN. BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial. Clin Cancer Res 2017;23:2460-70. [PMID: 27827316 DOI: 10.1158/1078-0432.CCR-16-1640] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
9 Segedi M, Anderson LN, Espin-Garcia O, Borgida A, Bianco T, Cheng D, Chen Z, Patel D, Brown MC, Xu W, Reisman D, Gallinger S, Cotterchio M, Hung R, Liu G, Cleary SP. BRM polymorphisms, pancreatic cancer risk and survival. Int J Cancer 2016;139:2474-81. [PMID: 27487558 DOI: 10.1002/ijc.30369] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
10 Diederichs S, Bartsch L, Berkmann JC, Fröse K, Heitmann J, Hoppe C, Iggena D, Jazmati D, Karschnia P, Linsenmeier M, Maulhardt T, Möhrmann L, Morstein J, Paffenholz SV, Röpenack P, Rückert T, Sandig L, Schell M, Steinmann A, Voss G, Wasmuth J, Weinberger ME, Wullenkord R. The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations. EMBO Mol Med 2016;8:442-57. [PMID: 26992833 DOI: 10.15252/emmm.201506055] [Cited by in Crossref: 138] [Cited by in F6Publishing: 141] [Article Influence: 23.0] [Reference Citation Analysis]
11 Thompson KW, Marquez SB, Lu L, Reisman D. Induction of functional Brm protein from Brm knockout mice. Oncoscience 2015;2:349-61. [PMID: 26097869 DOI: 10.18632/oncoscience.153] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
12 Marquez SB, Thompson KW, Lu L, Reisman D. Beyond Mutations: Additional Mechanisms and Implications of SWI/SNF Complex Inactivation. Front Oncol 2014;4:372. [PMID: 25774356 DOI: 10.3389/fonc.2014.00372] [Cited by in Crossref: 16] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
13 Kahali B, Yu J, Marquez SB, Thompson KW, Liang SY, Lu L, Reisman D. The silencing of the SWI/SNF subunit and anticancer gene BRM in Rhabdoid tumors. Oncotarget 2014;5:3316-32. [PMID: 24913006 DOI: 10.18632/oncotarget.1945] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
14 Jiang LL, Ruan LW. Association between FOXP3 promoter polymorphisms and cancer risk: A meta-analysis. Oncol Lett 2014;8:2795-9. [PMID: 25364468 DOI: 10.3892/ol.2014.2585] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
15 Gao XR, Zhang SL, Yang YF, Han GR. FEN1 -69G>A and 4150G>T polymorphisms and cancer risk in Chinese population. Sci Rep 2014;4:6183. [PMID: 25154853 DOI: 10.1038/srep06183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
16 Hu T, Zhao H, Wang K, Sun W, Li L, Wang W. Association of IL-27 polymorphisms and cancer risk in Chinese population. J Recept Signal Transduct Res 2015;35:180-3. [PMID: 25051492 DOI: 10.3109/10799893.2014.942465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
17 Simó-Riudalbas L, Esteller M. Cancer genomics identifies disrupted epigenetic genes. Hum Genet 2014;133:713-25. [PMID: 24104525 DOI: 10.1007/s00439-013-1373-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
18 Wang C, Zhao H, Zhao X, Wan J, Wang D, Bi W, Jiang X, Gao Y. Association between an insertion/deletion polymorphism within 3'UTR of SGSM3 and risk of hepatocellular carcinoma. Tumour Biol 2014;35:295-301. [PMID: 23918301 DOI: 10.1007/s13277-013-1039-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]